Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.39 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7209479 | 0.75 | CNR2 (0.40) | CYP1A2CYP2A6ALDH1A1HSD17B10TSHR | |
| SCHEMBL13261664 | 0.74 | ALDH1A1 (0.43) | CYP1A2CYP2A6ALDH1A1HSD17B10TSHR | |
| SCHEMBL17394560 | 0.73 | ALDH1A1 (0.38) | CYP1A2CYP2A6ALDH1A1HSD17B10TSHR | |
| SCHEMBL1097973 | 0.72 | CYP2A6 (0.41) | CYP1A2CYP2A6ALDH1A1HSD17B10TSHR | |
| SCHEMBL2008188 | 0.72 | CYP2A6 (0.41) | CYP1A2CYP2A6ALDH1A1HSD17B10TSHR | |
| SCHEMBL10605324 | 0.71 | HSD17B10 (0.38) | CYP1A2PTPN22TRPM4CYP2A6ALDH1A1 | |
| SCHEMBL2008190 | 0.70 | ALDH1A1 (0.42) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL21177767 | 0.70 | CYP2A6 (0.39) | CYP1A2CYP2A6ALDH1A1HSD17B10TSHR | |
| SCHEMBL276253 | 0.70 | ALDH1A1 (0.39) | CYP1A2CYP2A6ALDH1A1HSD17B10TSHR | |
| SCHEMBL3149291 | 0.70 | ALDH1A1 (0.42) | CYP1A2CYP2A6ALDH1A1HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190221750-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-18 | — | — | US | claimed |
| US-20190185457-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2019-06-20 | — | — | US | claimed |
| US-5594020-A | FUNGICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-14 | — | — | US | claimed |
| US-11997917-B2 | Quantum dot electroluminescence device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-05-28 | — | — | US | disclosed |
| EP-3674290-B1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-05-22 | — | — | EP | disclosed |
| US-20240114765-A1 | QUANTUM DOT ELECTROLUMINESCENCE DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-04-04 | — | — | US | disclosed |
| US-11925106-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-03-05 | — | — | US | disclosed |
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-11697645-B2 | Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-11 | — | — | US | disclosed |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| EP-4174054-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | Samsung Electronics Co., Ltd. (KR) | 2023-05-03 | — | — | EP | disclosed |
| EP-1816152-A1 | POLYMERIZABLE COMPOSITION | TOYO INK MFG. CO., LTD. (JP) | 2007-08-08 | — | — | EP | disclosed |
| CN-1798739-A | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators | NISSAN CHEMICAL IND LTD (JP) | 2006-07-05 | — | — | CN | disclosed |
| WO-2006062240-A1 | 3-ETHYLIDENEHYDRAZINO SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2006-06-15 | — | — | WO | disclosed |
| US-20060094694-A1 | Heterocyclic compounds and thrombopoietin receptor activators | NISSAN CHEMICAL INDUSTRIES LIMITED (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1636192-A1 | 3-ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS | Nissan Chemical Industries, Ltd. (JP) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004108683-A1 | 3-ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-12-16 | — | — | WO | disclosed |
| US-5719171-A | INSECTICIDES; MITICIDES; NEMATOCIDES; FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-02-17 | — | — | US | disclosed |
| US-5594020-A | FUNGICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-14 | — | — | US | disclosed |
| EP-0621277-A2 | Diarylderivatives and their use for the protection of plants | BASF Aktiengesellschaft (DE) | 1994-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11697645-B2 | Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound | CYP1B1, CYP1A1, CCNT1 | CYP1A2 111/4885PTPN22 4727/4885TRPM4 925/4885 |
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CRY1, CYP1B1, CYP1A1 | CYP1A2 19/4885PTPN22 4582/4885TRPM4 847/4885 |
| US-20060094694-A1 | Heterocyclic compounds and thrombopoietin receptor activators | NR2C2, ROR1, NR0B2 | CYP1A2 434/4885PTPN22 607/4885TRPM4 578/4885 |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | CYP1A2 64/4885PTPN22 4626/4885TRPM4 1630/4885 |
| US-11925106-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound | CCNB1, CCNA1, CCNT1 | CYP1A2 712/4885PTPN22 4624/4885TRPM4 1155/4885 |
| US-20190185457-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | CRY1, NAP1L1, CYP1A1 | CYP1A2 35/4885PTPN22 4218/4885TRPM4 1772/4885 |
| US-20190221750-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | CRY1, CRY2, MCM4 | CYP1A2 1494/4885PTPN22 4676/4885TRPM4 1145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.